Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users ivps42020-02-05T14:45:03-05:00February 6th, 2020|Press Release| Read More
Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery ivps42020-01-13T12:17:22-05:00January 13th, 2020|Press Release| Read More
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option ivps42019-12-19T13:49:43-05:00December 19th, 2019|Press Release| Read More
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering ivps42019-12-17T13:12:17-05:00December 17th, 2019|Press Release| Read More
Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program ivps42019-12-06T15:10:50-05:00December 9th, 2019|Press Release| Read More
Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program ivps42019-11-04T19:41:33-05:00November 6th, 2019|Press Release| Read More
Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019 ivps42019-10-30T13:20:39-05:00October 31st, 2019|Press Release| Read More
Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference ivps42019-10-23T13:06:26-05:00October 24th, 2019|Press Release| Read More
Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study ivps42019-09-27T14:24:05-05:00September 30th, 2019|Press Release| Read More
Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference ivps42019-09-11T12:16:31-05:00September 13th, 2019|Press Release| Read More